Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted LopinavirRitonavir

dc.citation.doi10.1128/AAC.01923-19
dc.citation.epage12
dc.citation.spage1
dc.contributor.authorTjokosela Tikiso
dc.contributor.authorJ LEE
dc.contributor.authorH Rabie
dc.contributor.authorLee Fairlie
dc.contributor.authorRenate Strehlau
dc.contributor.authorR Bobat
dc.contributor.authorAfaaf Liberty
dc.contributor.authoret al. et al.
dc.date.accessioned2023-10-09T12:50:45Z
dc.date.available2023-10-09T12:50:45Z
dc.identifier.citationWOS
dc.identifier.issn0066-4804
dc.identifier.urihttps://hdl.handle.net/10539/36598
dc.journal.titleANTIMICROBIAL AGENTS AND CHEMOTHERAPY
dc.journal.volume64
dc.titleAbacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted LopinavirRitonavir
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal.pdf
Size:
1.26 MB
Format:
Adobe Portable Document Format
Description:
Journal